• Job Opening for Radiochemist
    Project Scientist in Radiochemistry, University of California, DavisThe College of Engineering at the University of California, Davis, invites applications from qualified candidates for an associate project scientist position in Biomedical Engineering. Candidates should have a Ph.D. in Chemistry or a closely related field, and formal training in radiochemistry with a minimum of 5 years of postdoctoral ...
  • Recent publications
    New Journal of Clinical Investigation paper delineates curative protocols combining ablation and drug delivery (1/16). Wong AW, Fite BZ, Liu Y, Kheirolomoom A, Seo JW, Watson KD, Mahakian LM, Tam S, Zhang H, Foiret J, Borowsky AD, Ferrara KW, Ultrasound Ablation Enhances Drug Accumulation and Survival in Mammary Carcinoma, Journal of Clinical Investigation. Journal of Controlled Release ...
  • View the CNN video on the Ferrara laboratory
  • Katherine Ferrara elected to National Academy of Engineering
    Ultrasound engineer Katherine Ferrara elected to NAE Professor Katherine Ferrara, whose research has pioneered using ultrasound to image cancer and heart disease and who played a leadership role in establishing the Department of Biomedical Engineering at the University of California, Davis, has been elected to theNational Academy of Engineering, the highest professional recognition for an engineer
  • Collaboration with Jo lab in Nature Communications
    Collaboration with Jo lab in Nature Communications
  • UC Davis Researchers: Key Discovery Involving Omega-3 Fatty Acids and Cancer
    DAVIS–Researchers at the University of California, Davis have discovered a key mechanism by which dietary omega-3 fatty acids (fish oils) could reduce the tumor growth and spread of cancer, a disease that kills some 580,000 Americans a year. In groundbreaking research, the team of 16 scientists led by Dr. Guodong Zhang of the Bruce Hammock laboratory, Department ...
  • Presentation at the MRgFUS Symposium “Nanoparticles locate tumor, deliver drugs”
    Nanoparticles are under investigation for a wide range of cancer-management applications: from imaging tumour cells to targeted delivery of therapeutic drugs. Now, researchers at the University of California, Davis are developing ultrasound-activated liposomes that can combine tumour imaging and therapy within a single system.


Comments are closed.